Harats N, Kluve-Beckerman B, Skinner M, Passo M, Quinn L, Benson M D
Department of Medicine, Indiana University School of Medicine, Richard L. Roudebush Veterans Administration Medical Center, Indianapolis.
Arthritis Rheum. 1989 Oct;32(10):1325-7. doi: 10.1002/anr.1780321021.
The prevalence of a recently described restriction fragment length polymorphism using Msp I for the serum amyloid P gene was determined in 5 groups of patients. Patients with reactive (secondary) amyloidosis, juvenile rheumatoid arthritis, related inflammatory conditions, or juvenile rheumatoid arthritis with reactive amyloidosis, and healthy control subjects were found to be polymorphic for 8.8-kb and 5.6-kb gene fragments; they either had one or the other or both fragments. No significant differences were seen between these groups with relation to this polymorphism, and no correlation with the presence of reactive amyloidosis was observed.
在5组患者中测定了最近描述的使用Msp I对血清淀粉样蛋白P基因进行的限制性片段长度多态性的患病率。发现反应性(继发性)淀粉样变性、青少年类风湿性关节炎、相关炎症性疾病或伴有反应性淀粉样变性的青少年类风湿性关节炎患者以及健康对照者对于8.8 kb和5.6 kb基因片段具有多态性;他们要么有其中一个片段,要么有另一个片段,要么两个片段都有。这些组之间在这种多态性方面没有观察到显著差异,并且未观察到与反应性淀粉样变性的存在有相关性。